CJC-1295 dosage by bodyweight
Reference dose ranges scaled across bodyweight bands, anchored to the most-cited research dose (100 mcg @ 75 kg). Educational only, never a recommendation.
| Bodyweight band | Reference dose range | At U-100 (1 mg/mL) | Vol. on U-100 (5 mg / 2 mL) | 5× t½ elapsed |
|---|---|---|---|---|
| <60 kg / <132 lb | 62–84 mcg | 0.06–0.08 mL | 3–3 units0.02–0.03 mL | 2.5 h |
| 60–75 kg / 132–165 lb | 77–103 mcg | 0.08–0.10 mL | 3–4 units0.03–0.04 mL | 2.5 h |
| 75–90 kg / 165–198 lb | 94–126 mcg | 0.09–0.13 mL | 4–5 units0.04–0.05 mL | 2.5 h |
| 90–105 kg / 198–231 lb | 111–150 mcg | 0.11–0.15 mL | 4–6 units0.04–0.06 mL | 2.5 h |
| >105 kg / >231 lb | 128–173 mcg | 0.13–0.17 mL | 5–7 units0.05–0.07 mL | 2.5 h |
Volume column assumes a standard 5 mg vial reconstituted with 2 mL bacteriostatic water (concentration 2.5 mg/mL); insulin units shown for a U-100 syringe. Five half-lives is the conventional washout window where ~3% of peak plasma remains, a useful "next dose due" anchor for CJC-1295 (t½ 30 min).
CJC-1295 by goal
Read CJC-1295's profile and dosing through a specific research-goal lens.
Dose & PK references
Selected from the CJC-1295 bibliography for relevance to dosing and pharmacokinetics.
- Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography
- Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.